Cure8 research brief
Why This Matters
Vitamin D deficiency is common in people with IBD and may relate to disease activity, complications, and quality of life; understanding this link could influence monitoring and adjunctive care.
Who Should Pay Attention
Adult patients with IBD (Crohn's disease or ulcerative colitis), clinicians who manage IBD, and researchers studying immune pathways, the microbiome, or nutritional modifiers of disease.
Study Snapshot
What To Know
This article is a literature review of studies on vitamin D and IBD covering publications through mid-2025. The authors report that vitamin D supports epithelial barrier integrity and influences gut microbiome composition, and that vitamin D deficiency is common in IBD patients and associated with worse disease-related outcomes and quality of life.
The review notes an association between low vitamin D levels and higher risk of malignancy and surgical needs in IBD, but it highlights uncertainty about causality — whether deficiency contributes to disease development or results from it.
Therapeutic use of vitamin D in IBD remains unresolved: the review indicates potential benefits but concludes that definitive evidence for vitamin D as a treatment is lacking and further research is needed.
Keep In Mind
This paper is a literature review (abstract-level content provided). It summarizes associations reported in prior studies but does not provide new randomized trial evidence proving benefit of vitamin D supplementation for IBD outcomes. Observational associations do not prove causation.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.